We are live on ! Find out more
KFS

Kurt F. Somerville Portfolio holdings

AUM $379M
1-Year Est. Return 19.42%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+19.42%
3 Year Est. Return
+62.7%
5 Year Est. Return
+83.65%
10 Year Est. Return
+302.17%
AUM
$593M
AUM Growth
+$8.66M
Cap. Flow
-$3.07M
Cap. Flow %
-0.52%
Top 10 Hldgs %
42.85%
Holding
100
New
1
Increased
22
Reduced
48
Closed
2

Top Sells

Rank Stock Value
1
NKE icon
Nike
NKE
+$4.3M
2
NVS icon
Novartis
NVS
+$2.23M
3
CVS icon
CVS Health
CVS
+$2.12M
4
NVDA icon
NVIDIA
NVDA
+$1.03M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$948K

Sector Composition

Rank Sector Weight
1 Technology 32.3%
2 Healthcare 20.05%
3 Industrials 12.6%
4 Consumer Discretionary 10.97%
5 Consumer Staples 5.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CARR icon
26
Carrier Global
CARR
$50.3B
$6.02M 1.01%
95,445
+45,865
+93% +$2.82M
VRTX icon
27
Vertex Pharmaceuticals
VRTX
$124B
$5.67M 0.96%
12,098
+7,300
+152% +$3.17M
BALL icon
28
Ball Corp
BALL
$17.6B
$5.3M 0.89%
88,287
+40,613
+85% +$2.72M
NEE icon
29
NextEra Energy
NEE
$185B
$5.06M 0.85%
71,445
+2,225
+3% +$158K
HON icon
30
Honeywell
HON
$77.3B
$5.04M 0.85%
25,056
-1,737
-6% -$331K
ASML icon
31
ASML
ASML
$607B
$4.66M 0.78%
4,510
+75
+2% +$72.1K
XOM icon
32
ExxonMobil
XOM
$649B
$4.03M 0.68%
35,001
-10
-0% -$1.17K
PEP icon
33
PepsiCo
PEP
$197B
$3.81M 0.64%
23,074
-2,720
-11% -$469K
LLY icon
34
Eli Lilly
LLY
$1.09T
$3.58M 0.6%
3,950
-310
-7% -$248K
APTV icon
35
Aptiv
APTV
$12.4B
$3.49M 0.59%
49,615
+4,420
+10% +$340K
NVS icon
36
Novartis
NVS
$302B
$3.32M 0.56%
31,225
-22,259
-42% -$2.23M
MKC icon
37
McCormick & Company Non-Voting
MKC
$14.1B
$2.89M 0.49%
+40,761
New +$2.97M
MRK icon
38
Merck
MRK
$324B
$2.58M 0.43%
20,831
-50
-0.2% -$6.44K
NKE icon
39
Nike
NKE
$64.1B
$2.29M 0.39%
30,428
-46,300
-60% -$4.3M
ADBE icon
40
Adobe
ADBE
$106B
$2.09M 0.35%
3,765
+767
+26% +$371K
CVS icon
41
CVS Health
CVS
$136B
$2.07M 0.35%
35,085
-33,953
-49% -$2.12M
V icon
42
Visa
V
$703B
$1.6M 0.27%
6,082
-50
-0.8% -$13.7K
BRK.B icon
43
Berkshire Hathaway Class B
BRK.B
$1.1T
$1.53M 0.26%
3,749
-150
-4% -$61.3K
EOG icon
44
EOG Resources
EOG
$77.4B
$1.49M 0.25%
11,830
ORLY icon
45
O'Reilly Automotive
ORLY
$75.2B
$1.42M 0.24%
20,100
-150
-0.7% -$10.4K
IVV icon
46
iShares Core S&P 500 ETF
IVV
$869B
$1.39M 0.23%
2,541
-400
-14% -$210K
KO icon
47
Coca-Cola
KO
$383B
$1.34M 0.23%
21,080
-1,100
-5% -$68.1K
ABBV icon
48
AbbVie
ABBV
$471B
$1.28M 0.22%
7,452
-25
-0.3% -$4.14K
NVO
49
Novo Nordisk
NVO
$229B
$1.26M 0.21%
8,820
-920
-9% -$122K
CL icon
50
Colgate-Palmolive
CL
$74.7B
$1.15M 0.19%
11,884
-300
-2% -$27.7K

Similar funds

Kurt F. Somerville's Q2 2024 Portfolio in Review

As of Q2 2024, Kurt F. Somerville held 100 positions worth $593M, up 1.5% from $585M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Trading was light in Q2 2024: portfolio turnover was 3%. Kurt F. Somerville opened 1 new position and exited 2, leaving the 100-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Industrials.

  • Kurt F. Somerville's largest Q2 2024 buy was McCormick & Company Non-Voting: 40,761 shares worth $2.89M.
  • Kurt F. Somerville added most to Vertex Pharmaceuticals in Q2 2024, an estimated $3.17M increase.
  • Kurt F. Somerville's biggest Q2 2024 reduction was Nike, cutting an estimated $4.3M.
  • Kurt F. Somerville fully exited Illumina in Q2 2024, selling an estimated $334K.
  • Kurt F. Somerville's ten largest holdings make up 43% of its $593M portfolio in Q2 2024.
  • Kurt F. Somerville opened 1 new position and closed 2 in Q2 2024.
  • Kurt F. Somerville's portfolio value rose 1.5% quarter-over-quarter to $593M.

Based on Kurt F. Somerville's 13F filing for Q2 2024, filed 12 Aug 2024.